Silicon Laboratories Inc.
SLAB
$145.85
$4.463.15%
NASDAQ
| 10/04/2025 | 07/05/2025 | 04/05/2025 | 12/28/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.80% | 32.66% | 67.06% | 91.43% | -18.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.80% | 32.66% | 67.06% | 91.43% | -18.34% |
| Cost of Revenue | 14.32% | 23.19% | 55.80% | 77.14% | -10.21% |
| Gross Profit | 31.79% | 41.17% | 77.55% | 105.40% | -24.12% |
| SG&A Expenses | 18.71% | 11.53% | 24.10% | 8.26% | 32.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.34% | 11.54% | 26.76% | 21.83% | 2.38% |
| Operating Income | 58.46% | 52.38% | 45.75% | 60.84% | -343.17% |
| Income Before Tax | 64.07% | 57.61% | 49.80% | 69.63% | -292.92% |
| Income Tax Expenses | -79.35% | -93.09% | 593.25% | 86.57% | -40.82% |
| Earnings from Continuing Operations | 65.14% | 73.44% | 46.10% | 65.86% | -375.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.14% | 73.44% | 46.10% | 65.86% | -375.45% |
| EBIT | 58.46% | 52.38% | 45.75% | 60.84% | -343.17% |
| EBITDA | 78.04% | 63.10% | 56.07% | 71.85% | -172.41% |
| EPS Basic | 65.70% | 73.90% | 47.02% | 66.47% | -371.11% |
| Normalized Basic EPS | 64.65% | 58.33% | 50.66% | 70.17% | -289.85% |
| EPS Diluted | 65.70% | 73.83% | 46.93% | 66.52% | -375.69% |
| Normalized Diluted EPS | 64.65% | 58.33% | 50.66% | 70.17% | -291.55% |
| Average Basic Shares Outstanding | 1.63% | 1.74% | 1.74% | 1.80% | 1.61% |
| Average Diluted Shares Outstanding | 1.63% | 1.74% | 1.74% | 1.80% | 0.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |